Merck’s Enlicitide, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with HeFH in Phase 3 ...

In this excerpt from the new book ‘Speak Data,’ the Wharton professor and best-selling author shares his thoughts on how we interpret and communicate information Data is an omnipresent facet of modern ...

Rezdiffra® treatment significantly improved liver stiffness, fibrosis biomarkers, and markers of clinically significant portal hypertension risk ...

Thousands of climate protesters marched through the Brazilian city of Belem on Saturday in a noisy, diverse and peaceful ...

The infrastructure requirement for America’s AI overhaul is fostering the breaking of bread across partisan lines in the hinterlands.

Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, is presenting ...

As artificial intelligence moves deeper into healthcare, executive teams are grappling with how to make it operational, safe, and sustainable. During the AI Summit at Becker’s 13th Annual CEO+CFO ...

Each year, the European Lung Foundation (ELF) recognises outstanding research that advances patient-centred care and promotes ...

Merck’s enlicitide decanoate significantly reduced LDL-C in adults with heterozygous familial hypercholesterolemia in phase 3 CORALreef HeFH trial: Rahway, New Jersey Tuesday, N ...

The prevailing assumption is that executives only need high-level briefings, not practical AI training. That's wrong.

When a mother is anaemic during pregnancy, her child is more likely to be born premature, underweight and with iron ...

Detailed price information for Mirum Pharmaceuticals Inc (MIRM-Q) from The Globe and Mail including charting and trades.